In recent decades, the survival rates of patients with rectal cancer have notably improved following the adoption of TME [20]. In 2009, Hohenberger et al. introduced a similar concept, CME, for individuals with colon cancer [1]. CME uses the TME principles that prioritize CVL and meticulous dissection along embryological planes to enable en bloc removal of the affected colon and its mesentery, thereby reducing the risk of microscopic tumor cell dissemination. However, this concept is controversial because of concerns regarding the increased risk of intraoperative complications [21, 22].
Laparoscopic surgery presents several inherent technical challenges in patients requiring right hemicolectomy with CME. Furthermore, achieving central lymphadenectomy at the level of the MCA, as per the CVL concept, using laparoscopic instruments, is technically demanding.
Robotic surgery has potential advantages over conventional laparoscopic surgery for performing complex procedures. These advantages are derived from features such as a stable 3-D surgeon-controlled camera and wrist-mounted instruments, which allow precise dissections around the pancreas and along the SMA and SMV, which are difficult to perform laparoscopically [19].
Only one randomized controlled trial (RCT) compared robotic and laparoscopic right colectomies; the main findings were that robotic right colectomy increases costs and prolongs operative times compared to laparoscopic right colectomy [9]. However, recent meta-analyses have indicated that robotic right colectomy results in a reduced length of hospital stay, quicker time to flatus, increased lymph node harvest, decreased estimated blood loss, reduced conversion rates, and fewer overall complications than laparoscopic right colectomy. In contrast, robotic right colectomy is associated with longer operative durations and higher expenses [23, 24].
In CME for right-sided colon cancer, dissection of the pancreatic head is critical. Uyama et al. suggested that robotic surgery, compared to laparoscopy, decreases the incidence of pancreatic leakage in gastric cancer surgeries that require pancreatic head dissection [25]. Therefore, we believe that robotic operations with joint functions can be utilized for dissection around the head of the pancreas.
Additionally, to ensure safe execution of CME/CVL, we employed a cranial approach. This method offers the following advantages: 1) early transection of the base of the transverse mesocolon, which is central to the lymphatic flow; 2) safe management of the venous system around the pancreatic head; and 3) elimination of the need to remove the small intestine from the surgical field. By initiating the dissection cranially, we can prepare these critical areas for optimal visualization, thereby enhancing the safety and precision of CME.
To date, only a few studies [18, 26]have reported on robotic surgery using a cranial approach, and few have verified its usefulness. In this study, robotic CME was comparable to laparoscopic CME in terms of the operative time and showed good results in terms of intraoperative blood loss. Several studies comparing robotic and laparoscopic colectomy have reported that robotic surgery takes longer than laparoscopic surgery [27, 28]. However, the results of this study indicated that the cranial approach has the potential to shorten the surgical time compared with other approaches. One reason is that manipulation of the small intestine is avoided, which is the most difficult aspect of robotic surgery. In robotic surgery, where the gripping force of the forceps is strong, there is a high possibility of damage to the small intestine due to compression; therefore, the cranial approach, which involves minimal removal of the small intestine in the surgical field, is particularly useful in robotic surgery compared to other approaches.
Additionally, surgical procedures involving bipolar dissection with joint function enable safe CME. For example, using an energy device in the left hand reduces the number of forceps exchanges and is also useful in shortening the operative time [29].
In this study, the time to first flatus was significantly earlier and the length of hospital stay was shorter in the R-CME group than in the L-CME group. This occurred due to the reduced need to grasp the small intestine to create a surgical field and the high rate of intracorporeal anastomosis.
Regarding intracorporeal anastomosis, the quick recovery of digestive tract peristalsis leads to a shorter hospital stay [30, 31]. Owing to the multi-joint function and good operability of robotic surgery, intracorporeal anastomosis is easier to perform than laparoscopic surgery; as a result, intracorporeal anastomosis can be promoted. In contrast, some reports have shown that intracorporeal anastomosis by robotic surgery results in longer operative times than extracorporeal anastomosis [32, 33]. However, if the surgical strategy takes advantage of the characteristics of robotic surgery, even intracorporeal anastomosis can have shorter operative times and ultimately improved perioperative outcomes.
A Pfannenstiel incision was made in the lower abdomen before the procedure to enable specimen extraction without undocking the robot. A Pfannenstiel incision reduces postoperative incisional hernias and the incidence of surgical site infections (SSI) [34]. To maximize the benefits of robotic right-sided colectomy, the combination of intracorporeal anastomosis and a Pfannenstiel incision is very promising.
To the best of our knowledge, this is the first study to compare R-CME with L-CME using a cranial approach. Nevertheless, this study had several limitations, primarily owing to its small sample size and retrospective design. Additionally, the lack of mesocolic plane grading, which is a key component of CME and CVL, is noteworthy. As previously mentioned, most R-CME procedures use intracorporeal anastomosis, whereas many L-CME procedures use extracorporeal anastomosis. This distinction may affect short-term outcomes. Furthermore, not all team members performed R-CME, and we lacked the long-term data needed to determine whether the short-term advantages of R-CME would lead to oncological benefits over L-CME. These factors may have introduced bias into our conclusions. To overcome the limitations of this retrospective analysis, a multicenter randomized controlled trial involving this procedure will be conducted.